We describe a simple method for calculating the pharmacological activity of an agonist (A) relative to a standard agonist (S) using only the concentration-response curves of the two agonists. In most situations, we show that the product of the ratios of maximal responses (E max − A/E max − S) and potencies (EC50 − S/EC50 − A) is equivalent to the product of the affinity and intrinsic efficacy of A expressed relative to that of S. We refer to this term as the IRA value of A. In a cooperative system where the concentration-response curve of the standard agonist is steep and that of the test agonist is flatter with a lower maximal response, the simple calculation of IRA described above underestimates agonist activity; however, we also describe...
When an agonist activates a population of G protein-coupled receptors (GPCRs), it elicits a signalin...
Molecular dynamics (MD) is the common computational technique for assessing efficacy of GPCR-bound l...
A protocol for predicting full agonist, partial agonist, and antagonist profiles of compounds with M...
We developed novel methods for analyzing the concentration-response curve of an agonist to estimate ...
We measured the intrinsic relative activity (RAi) of muscarinic agonists to detect possible selectiv...
We describe a modification of receptor theory that enables the estimation of relative affinity const...
We describe a modification of receptor theory for the estimation of observed affinities (Kobs) and r...
We measured the influence of gallamine on the functional responses and binding properties of selecte...
The ability of forskolin and isoproterenol to inhibit the contractile action of the muscarinic agoni...
We investigated the ability of the muscarinic antagonist p-fluorohexahydrosiladifenidol to inhibit m...
We investigated the effects of pertussis toxin treatment on acetylcholine-induced desensitization of...
Newly-developed methods for estimation of in vivo binding to neurotransmitter receptors should enabl...
The effects of structurally diverse agonists were assessed on receptor-mediated activation of G-prot...
Although there are several empirical approaches that enable the comparison of relative agonist effic...
Accurate ranking of efficacies and potencies of agonists is essential in the discovery of new select...
When an agonist activates a population of G protein-coupled receptors (GPCRs), it elicits a signalin...
Molecular dynamics (MD) is the common computational technique for assessing efficacy of GPCR-bound l...
A protocol for predicting full agonist, partial agonist, and antagonist profiles of compounds with M...
We developed novel methods for analyzing the concentration-response curve of an agonist to estimate ...
We measured the intrinsic relative activity (RAi) of muscarinic agonists to detect possible selectiv...
We describe a modification of receptor theory that enables the estimation of relative affinity const...
We describe a modification of receptor theory for the estimation of observed affinities (Kobs) and r...
We measured the influence of gallamine on the functional responses and binding properties of selecte...
The ability of forskolin and isoproterenol to inhibit the contractile action of the muscarinic agoni...
We investigated the ability of the muscarinic antagonist p-fluorohexahydrosiladifenidol to inhibit m...
We investigated the effects of pertussis toxin treatment on acetylcholine-induced desensitization of...
Newly-developed methods for estimation of in vivo binding to neurotransmitter receptors should enabl...
The effects of structurally diverse agonists were assessed on receptor-mediated activation of G-prot...
Although there are several empirical approaches that enable the comparison of relative agonist effic...
Accurate ranking of efficacies and potencies of agonists is essential in the discovery of new select...
When an agonist activates a population of G protein-coupled receptors (GPCRs), it elicits a signalin...
Molecular dynamics (MD) is the common computational technique for assessing efficacy of GPCR-bound l...
A protocol for predicting full agonist, partial agonist, and antagonist profiles of compounds with M...